Genomic strategies to untangle the etiology of autism: A primer.

Vashisth et al. (2023) wrote a plain-language tour of the newest DNA tools used in autism research. They map which rare or common gene changes are now linked to ASD and explain how the newer tests work.

The paper is a narrative review, not a new experiment. It gathers 15 years of gene discoveries so clinicians can see why today’s autism cases look so different from one another.

The authors show that autism rarely stems from one “autism gene.” Instead, it is a pile-up of many small DNA spelling changes, some inherited and some brand-new.

Newer machines can now read every letter of a person’s DNA in days. These fast scans are finding more hidden changes than the older tests that only looked at single chromosomes.

Ahlborn et al. (2008) asked the same questions 15 years earlier. Vashisth et al. (2023) supersedes that work by adding data from huge sequencing projects that did not exist in 2008. The newer paper keeps the old roadmap but updates every stop with fresher findings.

Hall et al. (2014) argued that switches on top of the DNA—epigenetics—matter as much as the DNA code itself. Vashisth et al. (2023) extends this view: they keep the focus on DNA variants but leave room for epigenetic layers, showing the two ideas stack rather than clash.

Huang et al. (2019) used one of the new tools—transcriptome-wide analysis—to flag 85 ASD-linked genes. Shayal’s primer places that study in context, treating it as an example of how modern scans move from long lists to real candidate genes.

For BCBAs, the paper is a quick update you can give to families who ask, “Why did my child get autism?” You can explain that many tiny genetic differences mix together, and that newer blood tests can sometimes answer questions older tests missed. The review also reminds us that every child’s genetic mix is unique—so our ABA programs must stay just as individualized.